Moreover, EZH2 levels in the serum of bladder cancer patients were significantly higher than those in healthy control individuals, and the median serum EZH2 levels were 36.23 ng/ml and 8.12 ng/ml, respectively (Figure 2). The gene discussed is EZH2; the disease is urinary bladder carcinoma.